Feeds:
Posts
Comments

Search Results for 'monoclonal antibody'

Race to develop antibody drugs for COVID-19 Reporter: Irina Robu, PhD Even at the record pace vaccines are moving, the first vaccine for COVID-19 might not be available until next year. And even if it is available, it will take longer for enough people within the population to be vaccinated in order to achieve herd […]

Read Full Post »

A Series of Recently Published Papers Report the Development of SARS-CoV2 Neutralizing Antibodies and Passive Immunity toward COVID19 Curator: Stephen J. Williams, Ph.D.   Passive Immunity and Treatment of Infectious Diseases The ability of one person to pass on immunity to another person (passive immunity) is one of the chief methods we develop immunity to […]

Read Full Post »

A new mechanism of action to attack in the treatment of coronary artery disease (CAD), Novartis developed Ilaris (canakinumab), a human monoclonal antibody targeting the interleukin-1beta innate immunity pathway Reporter: Aviva Lev-Ari, PhD, RN   Speaking at an ESC press briefing, Ridker said, “This is what personalized predictive medicine is all about.” Once a patient has […]

Read Full Post »

Despite heated discussion over whether it works, the FDA has approved Aduhelm, bringing a new ray of hope to the Alzheimer’s patients. Curator and Reporter: Dr. Premalata Pati, Ph.D., Postdoc On Monday, 7th June 2021, a controversial new Alzheimer’s Disease treatment was licensed in the United States for the first time in nearly 20 years, […]

Read Full Post »

Need for Global Response to SARS-CoV-2 Viral Variants Reporter: Aviva Lev-Ari, PhD, RN NIH experts discuss SARS-CoV-2 viral variants Editorial emphasizes need for global response.   The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has attracted the attention of health and science experts worldwide. In an editorial published today in JAMA: […]

Read Full Post »

12/5/2020 Regeneron’s Covid Antibody coktail has been cleared for emergency use by the FDA. The emergency authorization for REGN-COV2, a combination of monoclonal antibodies casiriviamb and imdevimab, marks the second for the antibody therapy. The first emergency authorization was given to Eli Lily’s bamlanivimab. The difference that REGN-COV2 is a concoction of several drugs, whereas […]

Read Full Post »

Severe COVID-19 in Patients experiencing Cytokine Storm: Positive Outcomes (faster respiratory recovery, a lower likelihood of mechanical ventilation, and fewer in-hospital deaths) of high dose methylprednisolone plus tocilizumab (Actemra, Genentech) vs Supportive Care Alone Reporter: Aviva Lev-Ari, PhD, RN   “COVID-19-associated cytokine storm syndrome [CSS] is an important complication of severe acute respiratory syndrome coronavirus-2 infection in up to 25% of […]

Read Full Post »

Miniproteins against the COVID-19 Spike protein may be therapeutic Reporter: Stephen J. Williams, PhD Computer-designed proteins may protect against coronavirus At a Glance Researchers designed “miniproteins” that bound tightly to the SARS-CoV-2 spike protein and prevented the virus from infecting human cells in the lab. More research is underway to test the most promising of […]

Read Full Post »

Pharmaceutical Companies Racing Together to Find a Cure for COVID-19 Reporter: Irina Robu, PhD The global outbreak has put pressure on companies and the Food and Drug Administration (FDA) to act quickly to make medications available to patients. Several companies are working together to find solutions to treat those infected by the virus and prevent […]

Read Full Post »

An Intelligent DNA Nanorobot to Fight Cancer by Targeting HER2 Expression Reporter and Curator: Dr. Sudipta Saha, Ph.D. 3.2.9   An Intelligent DNA Nanorobot to Fight Cancer by Targeting HER2 Expression, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene […]

Read Full Post »

Next »

%d bloggers like this: